“Epigenetic changes determine whether genes are turned on or off, and can potentially reverse disease, broadening the therapeutic landscape to find potential cures previously thought impossible.”

Company co-founded by Alex Aravanis and Feng Zhang targets epigenetic code to reprogram cells to a healthy state.